FDA Looks To Expand Drug GMPs Further Up The Pharmaceutical Supply Chain
This article was originally published in The Tan Sheet
Executive Summary
FDA looks to assert its regulatory authority further up the pharmaceutical supply chain with new good manufacturing practice requirements and an expansive interpretation of International Conference on Harmonization guidelines